Gene: MFSD11
Official Full Name: major facilitator superfamily domain containing 11provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16198 | MFSD11 Knockout cell line (HeLa) | Human | MFSD11 | 1:3~1:6 | Negative | Online Inquiry |
KO16199 | MFSD11 Knockout cell line (HCT 116) | Human | MFSD11 | 1:2~1:4 | Negative | Online Inquiry |
KO16200 | MFSD11 Knockout cell line (HEK293) | Human | MFSD11 | 1:3~1:6 | Negative | Online Inquiry |
KO16201 | MFSD11 Knockout cell line (A549) | Human | MFSD11 | 1:3~1:4 | Negative | Online Inquiry |
MFSD11 Gene Knockout Cell Lines are advanced cellular models specifically designed to facilitate the comprehensive study of the MFSD11 gene's function and its implications in various biological contexts. Gene knockout techniques involve the targeted deletion or inactivation of specific genes, enabling researchers to investigate the resulting phenotypic and functional changes in cultured cells. These cell lines serve as invaluable tools for elucidating the role of MFSD11 in physiological processes and disease mechanisms.
The primary function of MFSD11 Gene Knockout Cell Lines lies in their ability to help researchers dissect the molecular pathways influenced by the MFSD11 gene. By observing the cellular responses in the absence of this gene, scientists can unravel its contributions to important processes such as metabolic regulation, cellular transport mechanisms, and potentially, its links to conditions like neurodegenerative diseases. This mechanistic understanding can drive innovative therapeutic approaches.
From a scientific perspective, these cell lines hold significant importance in both research and clinical settings. They can be employed in drug discovery processes, enabling the screening of new therapeutic compounds that target the pathways associated with MFSD11. Furthermore, they provide insights into how mutations in this gene may lead to specific health conditions, guiding genetic counseling and the development of gene-based therapies.
What sets our MFSD11 Gene Knockout Cell Lines apart from alternatives is their high specificity and validation. Each cell line undergoes rigorous characterization to confirm successful gene knockout and maintains consistent growth and viability, allowing for reliable experimental outcomes. Researchers can trust these models to provide reproducible data, a critical factor in scientific investigations.
For researchers and clinicians, the value of using MFSD11 Gene Knockout Cell Lines lies in their ability to accelerate discovery and enhance understanding of fundamental biological processes. These cell lines not only foster advancements in the field of molecular biology but also hold the potential to translate findings into clinical applications.
Our commitment to excellence in cell line development is grounded in extensive expertise in genetic engineering and cell biology. Our portfolio includes a wide range of specialized biological products that empower scientists in their quest to discover and innovate at the intersection of biology, health, and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.